Searchable abstracts of presentations at key conferences in endocrinology

ea0022p428 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Malignant paraganglioma – the story of a long time survival

Balcan Roxana , Iliescu Dan , Stefanescu Cipriana , Popa Radu , Vasiliu Ioana , Idriceanu Jeanina , Zbranca Eusebie , Vulpoi Carmen

Introduction: Pheochromocytoma and paraganglioma are catecholamine secreting tumours. Malignancy is uncommon (approximately 10% for pheochromocytoma and 20% for paraganglioma) and surgery, when possible, is the first line treatment. However, the prognosis is poor because of frequent local recurrence and/or metastases and the lack of specific chemotherapeutic agents. CASE-REPORT: We present the case of a 60 years-old man who, at the age of 48, was diagnosed with paraganglioma. ...